Blog
Latest articles, insights, and updates from the blog.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
Pharmacokinetics of Ketamine: Absorption, Distribution, Metabolism, and Elimination
Learn how ketamine is absorbed, distributed, metabolized, and eliminated across IV, intranasal, oral, sublingual, IM, and subcutaneous routes.
Ketamine and the Default Mode Network: Neuroimaging Evidence
How does ketamine affect the brain's default mode network? A review of fMRI, MEG, and PET studies on DMN connectivity, depression, and treatment response.
Low-Dose Ketamine for Chronic Pain Syndromes
Learn when low dose ketamine may be considered for CRPS, neuropathic pain, and fibromyalgia, what research supports, and what to discuss with a pain clinician.
Renal and Hepatic Dose Adjustments for Low-Dose Ketamine
Learn how liver and kidney impairment can affect low-dose ketamine planning, monitoring, recovery, and questions to ask a prescribing clinician.
Defining Sub-Anesthetic Ketamine: Dose Ranges and Therapeutic Windows
Sub-anesthetic ketamine spans 0.1 to 1.0 mg/kg depending on indication. Learn how dose, NMDA receptor occupancy, and route shape each therapeutic window.
Ketamine, Neuroplasticity, and Brain-Derived Neurotrophic Factor
How does low-dose ketamine drive neuroplasticity? A look at BDNF release, TrkB and mTOR activation, and the synapse rebuilding behind its rapid antidepressant effect.
Meta-Analyses of Low-Dose Ketamine for Treatment-Resistant Depression
Meta-analyses of low-dose ketamine for treatment-resistant depression show large 24-hour effects and better durability for racemic ketamine than esketamine.
Rapid-Onset Antidepressant Mechanisms of Low-Dose Ketamine
Low-dose ketamine's rapid-onset antidepressant mechanisms explain why relief begins in hours, not weeks, via NMDA blockade and BDNF-driven synaptic growth.
Low-Dose Ketamine for Acute Suicidal Ideation: Clinical Evidence
A review of the clinical trial evidence examining low-dose ketamine as an intervention for acute suicidal ideation. This article evaluates randomized controlled trials, naturalistic studies, and emergency department protocols demonstrating ketamine's rapid anti-suicidal effects.
Low-Dose Ketamine for Treatment-Resistant Depression
Learn what research says about low dose ketamine for treatment-resistant depression, including rapid effects, safety monitoring, esketamine, and questions to ask a clinician.
Dose-Response Relationships in Low-Dose Ketamine Therapy
Learn why low dose ketamine therapy does not have one universal dose, how route and treatment goals affect response, and which questions to bring to follow-up.
Patient Selection Criteria for Low-Dose Ketamine Therapy
Learn how clinicians assess candidates for low dose ketamine therapy, including diagnosis, treatment history, safety screening, practical readiness, and monitoring.